Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$211,293,293
-$23,430,360 QoQ
Shares Held
3,357,059
+0.3% QoQ
Ownership
7.65%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#3
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. TARS ranks #15 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,993,687 | $1,070,510,234 | |
| 2 | ARGX |
Argenx SE
|
709,446 | $658,202,715 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,746,415 | $631,875,071 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
5,061,175 | $620,398,831 | |
| 5 | CGON |
CG Oncology, Inc.
|
8,514,590 | $604,961,619 | |
| 6 | INSM |
INSMED Inc
|
4,842,880 | $516,347,865 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
13,900,620 | $434,533,381 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
4,251,996 | $377,492,204 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,293,293 | 3,357,059 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $234,723,653 | 3,346,025 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $273,096,001 | 3,335,320 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $188,835,021 | 3,177,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $126,054,156 | 3,111,680 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $170,344,563 | 3,316,032 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $179,207,718 | 3,236,549 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $112,236,664 | 3,412,486 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $92,751,369 | 3,412,486 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $118,949,595 | 3,272,341 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $63,834,905 | 3,152,341 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $51,190,056 | 2,880,701 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $46,044,618 | 2,548,125 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $32,029,931 | 2,548,125 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,355,512 | 2,548,125 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $34,636,824 | 2,023,179 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,398,574 | 2,013,601 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $33,868,768 | 2,013,601 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $45,306,022 | 2,013,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $43,393,101 | 2,013,601 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $58,354,156 | 2,013,601 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $79,401,860 | 2,463,601 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $101,820,629 | 2,463,601 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||